Anti-Infective Agents Market
Anti-Infective Agents Market Analysis, By Type (Anti-Viral, Anti-Bacterial, Anti-Fungal, And Others), By Range (Narrow Spectrum and Broad Spectrum), By Route of Administration (IV, Oral, Topical, and Others), By Indication, Distribution Channel & By Region - Global Market Insights 2022 to 2032
Analysis of Anti-Infective Agents Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Anti-Infective Agents Market Outlook (2022 to 2032)
The global anti-infective agents market is expected to be worth US$ 141 Billion in fiscal year 2022, up from US$ 136 Billion in fiscal year 2021. From 2022 to 2032, the market is expected to grow at a 3.3% CAGR, reaching a value of US$ 195.8 Billion by the end of 2032.
Over the course of the projection period, new medication approvals are also anticipated to boost market growth. For instance, the Food and Drug Administration (FDA) authorized medications in 2016 such as Zepatier by Merck, which treats adult patients with chronic Hepatitis C virus (HCV) genotypes 1 or 4 infections, as well as Descovy by Gilead, which treats HIV-1 infection. From 2022 through 2032, these advancements will result in a greater need for anti-infective drugs
According to estimates, the market will rise as a result of factors including the rising prevalence of infectious disorders and antimicrobial resistance to already available anti-infective drugs. In addition, rising health consciousness, awareness of the accessibility of diagnostics for infectious illnesses, and preventable risks related to early detection are some of the elements anticipated to support development.
The FDA-approved, modified antibiotics Orbactiv (Oritavancin), Dalvance (Dalbavancin), Zevtera (Ceftobiprole), and Sivextro have recently been introduced by companies for the treatment of acute bacterial skin and soft tissue infections (Tedizolid). In the next few years, the anti-infective agents market is anticipated to rise as a result of the growing prevalence of these anti-infective treatments due to their enhanced efficacy.
| Report Attributes | Details |
|---|---|
| Anticipated Base Year Value (2021) | US$ 136 Billion |
| Expected Market Value (2022) | US$ 141 Billion |
| Projected Forecast Value (2032) | US$ 195.8 Billion |
| Global Growth Rate (2022 to 2032) | 3.3% |
| CAGR of North America (2022) | 4% |
| CAGR of APAC (2022 to 2032) | 3.1% |
| Prominent Players in The Global Market | Novartis AG; Sanofi SA; Pfizer Inc.; Johnson & Johnson Services Inc.; Alembic Pharmaceuticals; Mankind Pharma,; Merck & Co. Inc.; Bayer AG; Gilead Sciences; GSK |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
2017 to 2021 Anti-Infective Agents Market Demand Analysis Vs. Forecast 2022 to 2032
The global anti-infective agents market grew at a CAGR of 2.2% from 2017 to 2021, as per Fact.MR, a provider of market research and competitive intelligence. Due to the limitations put in place by several nations during the COVID-19 epidemic, numerous towns, industries, companies, and lifestyles were negatively impacted. The COVID-19 epidemic touched almost every industry.
Anti-infective agent use, however, has drawn attention in an effort to stop the transmission of the SARS-CoV-2 virus and other infectious diseases that aggravate the state of the affected population. The use of antimicrobial peptides and antibodies as anti-infective agents against the SARS-CoV-2 virus was proposed in an article titled "Antimicrobial Resistance in the COVID-19 Landscape: Is There an Opportunity for Anti-Infective Antibodies and Antimicrobial Peptides?" that was published in the journal Frontiers in Immunology in June 2022.
During the last two years, the market grew considerably as a result of the widespread usage of anti-infective agents to stop the spread of COVID-19 among the populace.
Due to the increasing frequency of certain diseases, growing awareness campaigns, and increased investments in anti-infective medication research and development, the market for anti-infective agents is predicted to expand gradually. Since many years ago, anti-infectives agents have been an important market for pharmaceutical businesses. The rate of infection has considerably increased during the past 20 years, especially in low- and middle-income nations.
Prominent Growth Drivers Influencing Anti-Infective Agents Industry
Increasing incidence of several infectious diseases across the globe
The primary factor fueling the market's expansion is the rising prevalence of a number of infectious diseases in developed and developing economies, including various strains of influenza, diarrhea, hepatitis, as well as urinary tract infections, which call for increased attention from the biotechnology and pharmaceutical industries.
For instance, according to a study published in the journal Frontiers in Public Health in October 2021 and titled "A Cross-Sectional Assessment of Urinary Tract Infections Among Geriatric Patients: Prevalence, Medication Regimen Complexity, and Factors Associated with Treatment Outcomes," urinary tract infections result in over 7 million hospital visits and 100,000 hospitalizations annually. The growing need for anti-infective medications to treat these disorders is anticipated to fuel market expansion.
Additionally, there has been a large increase in the number of multi drug resistant organisms in various regions of the world, which emphasizes the significance of anti-infective agent innovation even more. To raise public knowledge of infectious illnesses, a number of institutes have launched various programmes or campaigns.
To increase awareness of antimicrobial resistance, the World Health Organization, for instance, held the World Antimicrobial Awareness Week (WAAW) in November 2021 with the theme, "Spread Awareness, Stop Resistance." Such factors can be predicted to boost the demand in the global market for anti-infective agents.
Rising number patients who require long term treatments to boost the demand
The patient population is quite diverse, necessitating extended hospital stays as well as home care services. Additionally, it has been noted that governments in nations with rapid economic growth are becoming more interested in working with hospitals and multinational pharmaceutical companies to increase the rate at which antiviral agents are distributed to those who need them in a given region of the nation.
For instance, Pfizer Inc. stated in November 2021 that it had reached a deal with the US government to provide 10 million treatment courses of PAXLOVID, an experimental oral antiviral candidate for COVID-19. The business had also started bilateral outreach to almost 100 nations worldwide and had signed multiple advance purchase agreements with different nations. Such factors are predicted to increase significantly, which is likely to boost sales during the forecast period.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
What Could Possibly Hinder Anti-Infective Agents Industry Demand?
High cost of the drugs and poor reimbursement policies to hinder growth
The development of anti-infective medication resistance and its accompanying adverse effects, as well as a lack of resources in healthcare institutions, particularly in emerging nations, limit the study market's potential expansion.
The demand for items in this market is also declining as a result of the high cost of anti-infective medications. Additionally, the inadequate payment practises of various countries are inhibiting the market for anti-infectives from expanding smoothly on a worldwide scale.
Category-wise Insights
Which type is expected to gain traction during 2022 to 2032?
The anti-viral segment will gain the dominant Market Share
In the year 2021, the anti-viral segment by product type gained the maximum market share of almost 61%. This segment is expected to maintain its dominance throughout the forecast period too.
As various pharmaceutical companies look for ways to develop in lower- and middle-income nations, where the risk of epidemic infection is high, the anti-viral agents are anticipated to see rapid expansion throughout the course of the projection period.
Antiviral medications are prescription treatments that are mostly used to treat the flu, according to information published by the US Centers for Disease Control and Prevention in August 2021. Antiviral medications aid in reducing the chance of infection and shortening the length of the sick person's illness.
Infectious illness occurrence is increasing, public awareness of these diseases is expanding, and more research and development is being done in this field, all of which are contributing to the market's expansion. Due to the rising demand for anti-viral medications, a number of market companies have been concentrating on their manufacture and manufacturing.
For instance, the public health group Medicines Patent Pool (MPP), which is supported by the United Nations, and the pharmaceutical corporation Merck & Co. Inc. inked a voluntary license deal in October 2021. The goal of the agreement was to make it easier for people all over the world to obtain molnupiravir, an experimental oral COVID-19 antiviral drug used to treat mild-to-moderate COVID-19 among adults who run the risk of developing.
Which route of administration segment will be used for these products more often?
The oral route application of anti-infective agents will become dominant
The oral-route application segment will be the fastest growing segment during the forecast period with a 3.4% CAGR. In the year 2021, this segment acquired almost 32% of the market share.
Due to the development of new products and the existence of a robust pipeline, the oral route of administration will hold the majority of the market share in 2022. Oral treatments lessen hospital stays and the problems associated with central lines used for intravenous medication delivery. Such factors are expected to push the demand to new heights in the next ten years.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Region-wise Analysis
What is the outlook of the North American anti-infective agents market?
Advanced healthcare systems with constant developments to propel the regional demand
With a CAGR of 4% from 2022 to 2032, the North American region is anticipated to considerably contribute to the market growth during the research period. Over the course of the projection period, the market is anticipated to be driven by elements including an advanced healthcare infrastructure, high societal awareness, well-established distribution networks, and a strong e-commerce presence in both the United States and Canada.
Antivirals are recommended for the treatment of several infectious disorders by the Centers for Disease Control and Prevention (CDC) in the United States. For instance, the CDC released a leaflet in September 2021 endorsing the use of antiviral medications to treat influenza.
The Food and Drug Administration-approved medications zanamivir, oseltamivir phosphate, baloxavir marboxil, and peramivir were recommended by the CDC. Over the forecast period, such initiatives by governmental health organizations to encourage the use of antivirals in the country are anticipated to fuel the expansion of the anti-infective agents market.
Pharmaceutical businesses are able to expand in this region because of advantageous reimbursement regulations and the strong end-user purchasing power. Additionally, it enables pharmaceutical firms to boost their manufacturing capacities and spend more in financed collaborations with prominent academic medical centers to meet the demand for anti-infective medications across North America.
The market is also being helped by a number of significant companies in the industry. For instance, Phathom Pharmaceuticals, Inc., a biopharmaceutical firm focusing on discovering and commercializing innovative medicines for gastrointestinal illnesses, received FDA approval for VOQUEZNA TRIPLE PAK and VOQUEZNA DUAL PAK in May 2022. Such events are anticipated to accelerate market expansion over the anticipated time frame.
What can be expected from the APAC market for anti-infective agents?
Rising economic stability and disposable income will boost the demand during the forecast period
Throughout the anticipated period, APAC exhibits a significant market potential for anti-infective agents. According to the Fact.MR projections, the market will grow with a steady CAGR of 3.1% from 2022 to 2032.
Due to the existence of generics businesses, rising economic stability, and rising disposable income, the Region will witness increased demand. In the upcoming years, it is anticipated that the aging population and their greater vulnerability to infections would offer a potential development platform.
Start-up Scenario
The various start-ups in the market are aimed at enhancing their product with different varieties for the anti-infective agents.
- Spero Therapeutics is a company that creates drugs to treat drug-resistant bacterial infections. Tebipenem HBr, an oral carbapenem for pediatric infections, SPR720, an oral anti - microbial agent for the non-tuberculous treatment of mycobacterial lung disease, as well as SPR206, an intravenous (IV)-administered succeeding polymyxin analogue for gram-negative infectious diseases are among the novel product applicants the company is evolving.
- Locus Biosciences is a pharmaceuticals developer specializing in infectious illness and inflammatory diseases. For their medications, they work with a variety of anti-infective medicines. The business has created a platform that facilitates the creation of antimicrobials for infectious illnesses and allows for the design and delivery of unique CRISPR-Cas systems to certain bacteria.
Competitive Landscape
Novartis AG, Sanofi SA, Pfizer Inc.; Johnson & Johnson Services Inc.; Alembic Pharmaceuticals, Mankind Pharma, Merck & Co., Inc, Bayer AG; Gilead Sciences, and GSK are a few of the leading businesses in the anti-infective agents market.
- The United States Food and Drug Administration (USFDA) granted Alembic Pharmaceuticals final clearance for its investigational new drug application (ANDA) for Doxycycline Hyclate Delayed-Release Tablets in January 2022. The purpose of Doxycycline Hyclate Delayed-Release Tablets is to prevent the growth of germs that are resistant to antibiotics.
- Novartis announced the adoption of a new organizational structure and operating model in April 2022. These changes are intended to support the firm's aspirations for innovation, development, and productivity as a focused pharmaceuticals company in the ensuing ten years.
- Savior Mankind, a branch of Mankind Pharma devoted to life-saving injectables, was introduced in January 2022. Its medicines range from anti-infectives towards stroke as well as trauma therapy. By creating, manufacturing, commercializing, and providing inexpensive and accessible medications that meet patients' immediate medical requirements, Mankind Pharma hopes to help the community enjoy a healthy lifestyle.
Key Segments Covered in the Anti-Infective Agents Market Report
-
By Type :
- Anti-Viral
- Anti-Fungal
- Anti-Bacterial
-
By Range :
- Narrow-Spectrum
- Broad-Spectrum
-
By Route of Administration :
- IV
- Oral
- Topical
- Others
-
By Indication :
- HIV
- Tuberculosis
- Respiratory Infection
- Pneumonia
- Others
-
By Distribution Channel :
- Hospital Pharmacies
- Retail Pharmacies
- E-Commerce
- Others
-
By Region :
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa (MEA)
Table of Content
- 1. Executive Summary
- 2. Market Overview
- 3. Market Background
- 4. Global Market Analysis 2017 to 2021 and Forecast, 2022 to 2032
- 5. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Type
- 5.1. Anti-viral
- 5.2. Anti-bacterial
- 5.3. Anti-fungal
- 5.4. Others
- 6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Range
- 6.1. Narrow Spectrum
- 6.2. Broad Spectrum
- 7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Route of Administration
- 7.1. IV
- 7.2. Oral
- 7.3. Topical
- 7.4. Others
- 8. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Indication
- 8.1. HIV
- 8.2. Tuberculosis
- 8.3. Respiratory Infection
- 8.4. Pneumonia
- 8.5. Others
- 9. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Distribution Channel
- 9.1. Hospital Pharmacies
- 9.2. Retail Pharmacies
- 9.3. Specialty Pharmacies
- 9.4. E-Commerce
- 9.5. Others
- 10. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region
- 10.1. North America
- 10.2. Latin America
- 10.3. Europe
- 10.4. South Asia
- 10.5. East Asia
- 10.6. Oceania
- 10.7. MEA
- 11. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
- 12. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
- 13. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
- 14. South Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
- 15. East Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
- 16. Oceania Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
- 17. MEA Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
- 18. Key Countries Market Analysis
- 19. Market Structure Analysis
- 20. Competition Analysis
- 20.1. GlaxoSmithKline plc.
- 20.2. Pfizer Inc.
- 20.3. Bayer AG
- 20.4. Sanofi
- 20.5. Merck & Co., Inc.
- 20.6. Bristol-Myers Squibb Company
- 20.7. Abbott
- 20.8. Novartis AG
- 20.9. Johnson & Johnson Services Inc.
- 20.10. Gilead Sciences, Inc.
- 20.11. Astellas Pharma Inc.
- 21. Assumptions & Acronyms Used
- 22. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Value (US$ Mn) Forecast by Region, 2017 to 2032
Table 02: Global Market Value (US$ Mn) Forecast by Type, 2017 to 2032
Table 03: Global Market Value (US$ Mn) Forecast by Range, 2017 to 2032
Table 04: Global Market Value (US$ Mn) Forecast by Route of Administration , 2017 to 2032
Table 05: Global Market Value (US$ Mn) Forecast by Indication, 2017 to 2032
Table 06: Global Market Value (US$ Mn) Forecast by Distribution Channel, 2017 to 2032
Table 07: North America Market Value (US$ Mn) Forecast by Country, 2017 to 2032
Table 08: North America Market Value (US$ Mn) Forecast by Type, 2017 to 2032
Table 09: North America Market Value (US$ Mn) Forecast by Range, 2017 to 2032
Table 10: North America Market Value (US$ Mn) Forecast by Route of Administration , 2017 to 2032
Table 11: North America Market Value (US$ Mn) Forecast by Indication, 2017 to 2032
Table 12: North America Market Value (US$ Mn) Forecast by Distribution Channel, 2017 to 2032
Table 13: Latin America Market Value (US$ Mn) Forecast by Country, 2017 to 2032
Table 14: Latin America Market Value (US$ Mn) Forecast by Type, 2017 to 2032
Table 15: Latin America Market Value (US$ Mn) Forecast by Range, 2017 to 2032
Table 16: Latin America Market Value (US$ Mn) Forecast by Route of Administration , 2017 to 2032
Table 17: Latin America Market Value (US$ Mn) Forecast by Indication, 2017 to 2032
Table 18: Latin America Market Value (US$ Mn) Forecast by Distribution Channel, 2017 to 2032
Table 19: Europe Market Value (US$ Mn) Forecast by Country, 2017 to 2032
Table 20: Europe Market Value (US$ Mn) Forecast by Type, 2017 to 2032
Table 21: Europe Market Value (US$ Mn) Forecast by Range, 2017 to 2032
Table 22: Europe Market Value (US$ Mn) Forecast by Route of Administration , 2017 to 2032
Table 23: Europe Market Value (US$ Mn) Forecast by Indication, 2017 to 2032
Table 24: Europe Market Value (US$ Mn) Forecast by Distribution Channel, 2017 to 2032
Table 25: South Asia Market Value (US$ Mn) Forecast by Country, 2017 to 2032
Table 26: South Asia Market Value (US$ Mn) Forecast by Type, 2017 to 2032
Table 27: South Asia Market Value (US$ Mn) Forecast by Range, 2017 to 2032
Table 28: South Asia Market Value (US$ Mn) Forecast by Route of Administration , 2017 to 2032
Table 29: South Asia Market Value (US$ Mn) Forecast by Indication, 2017 to 2032
Table 30: South Asia Market Value (US$ Mn) Forecast by Distribution Channel, 2017 to 2032
Table 31: East Asia Market Value (US$ Mn) Forecast by Country, 2017 to 2032
Table 32: East Asia Market Value (US$ Mn) Forecast by Type, 2017 to 2032
Table 33: East Asia Market Value (US$ Mn) Forecast by Range, 2017 to 2032
Table 34: East Asia Market Value (US$ Mn) Forecast by Route of Administration , 2017 to 2032
Table 35: East Asia Market Value (US$ Mn) Forecast by Indication, 2017 to 2032
Table 36: East Asia Market Value (US$ Mn) Forecast by Distribution Channel, 2017 to 2032
Table 37: Oceania Market Value (US$ Mn) Forecast by Country, 2017 to 2032
Table 38: Oceania Market Value (US$ Mn) Forecast by Type, 2017 to 2032
Table 39: Oceania Market Value (US$ Mn) Forecast by Range, 2017 to 2032
Table 40: Oceania Market Value (US$ Mn) Forecast by Route of Administration , 2017 to 2032
Table 41: Oceania Market Value (US$ Mn) Forecast by Indication, 2017 to 2032
Table 42: Oceania Market Value (US$ Mn) Forecast by Distribution Channel, 2017 to 2032
Table 43: MEA Market Value (US$ Mn) Forecast by Country, 2017 to 2032
Table 44: MEA Market Value (US$ Mn) Forecast by Type, 2017 to 2032
Table 45: MEA Market Value (US$ Mn) Forecast by Range, 2017 to 2032
Table 46: MEA Market Value (US$ Mn) Forecast by Route of Administration , 2017 to 2032
Table 47: MEA Market Value (US$ Mn) Forecast by Indication, 2017 to 2032
Table 48: MEA Market Value (US$ Mn) Forecast by Distribution Channel, 2017 to 2032
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Value (US$ Mn) by Type, 2022 to 2032
Figure 02: Global Market Value (US$ Mn) by Range, 2022 to 2032
Figure 03: Global Market Value (US$ Mn) by Route of Administration , 2022 to 2032
Figure 04: Global Market Value (US$ Mn) by Indication, 2022 to 2032
Figure 05: Global Market Value (US$ Mn) by Distribution Channel, 2022 to 2032
Figure 06: Global Market Value (US$ Mn) by Region, 2022 to 2032
Figure 07: Global Market Value (US$ Mn) Analysis by Region, 2017 to 2032
Figure 08: Global Market Value Share (%) and BPS Analysis by Region, 2022 to 2032
Figure 09: Global Market Y-o-Y Growth (%) Projections by Region, 2022 to 2032
Figure 10: Global Market Value (US$ Mn) Analysis by Type, 2017 to 2032
Figure 11: Global Market Value Share (%) and BPS Analysis by Type, 2022 to 2032
Figure 12: Global Market Y-o-Y Growth (%) Projections by Type, 2022 to 2032
Figure 13: Global Market Value (US$ Mn) Analysis by Range, 2017 to 2032
Figure 14: Global Market Value Share (%) and BPS Analysis by Range, 2022 to 2032
Figure 15: Global Market Y-o-Y Growth (%) Projections by Range, 2022 to 2032
Figure 16: Global Market Value (US$ Mn) Analysis by Route of Administration , 2017 to 2032
Figure 17: Global Market Value Share (%) and BPS Analysis by Route of Administration , 2022 to 2032
Figure 18: Global Market Y-o-Y Growth (%) Projections by Route of Administration , 2022 to 2032
Figure 19: Global Market Value (US$ Mn) Analysis by Indication, 2017 to 2032
Figure 20: Global Market Value Share (%) and BPS Analysis by Indication, 2022 to 2032
Figure 21: Global Market Y-o-Y Growth (%) Projections by Indication, 2022 to 2032
Figure 22: Global Market Value (US$ Mn) Analysis by Distribution Channel, 2017 to 2032
Figure 23: Global Market Value Share (%) and BPS Analysis by Distribution Channel, 2022 to 2032
Figure 24: Global Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022 to 2032
Figure 25: Global Market Attractiveness by Type, 2022 to 2032
Figure 26: Global Market Attractiveness by Range, 2022 to 2032
Figure 27: Global Market Attractiveness by Route of Administration , 2022 to 2032
Figure 28: Global Market Attractiveness by Indication, 2022 to 2032
Figure 29: Global Market Attractiveness by Distribution Channel, 2022 to 2032
Figure 30: Global Market Attractiveness by Region, 2022 to 2032
Figure 31: North America Market Value (US$ Mn) by Type, 2022 to 2032
Figure 32: North America Market Value (US$ Mn) by Range, 2022 to 2032
Figure 33: North America Market Value (US$ Mn) by Route of Administration , 2022 to 2032
Figure 34: North America Market Value (US$ Mn) by Indication, 2022 to 2032
Figure 35: North America Market Value (US$ Mn) by Distribution Channel, 2022 to 2032
Figure 36: North America Market Value (US$ Mn) by Country, 2022 to 2032
Figure 37: North America Market Value (US$ Mn) Analysis by Country, 2017 to 2032
Figure 38: North America Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 39: North America Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 40: North America Market Value (US$ Mn) Analysis by Type, 2017 to 2032
Figure 41: North America Market Value Share (%) and BPS Analysis by Type, 2022 to 2032
Figure 42: North America Market Y-o-Y Growth (%) Projections by Type, 2022 to 2032
Figure 43: North America Market Value (US$ Mn) Analysis by Range, 2017 to 2032
Figure 44: North America Market Value Share (%) and BPS Analysis by Range, 2022 to 2032
Figure 45: North America Market Y-o-Y Growth (%) Projections by Range, 2022 to 2032
Figure 46: North America Market Value (US$ Mn) Analysis by Route of Administration , 2017 to 2032
Figure 47: North America Market Value Share (%) and BPS Analysis by Route of Administration , 2022 to 2032
Figure 48: North America Market Y-o-Y Growth (%) Projections by Route of Administration , 2022 to 2032
Figure 49: North America Market Value (US$ Mn) Analysis by Indication, 2017 to 2032
Figure 50: North America Market Value Share (%) and BPS Analysis by Indication, 2022 to 2032
Figure 51: North America Market Y-o-Y Growth (%) Projections by Indication, 2022 to 2032
Figure 52: North America Market Value (US$ Mn) Analysis by Distribution Channel, 2017 to 2032
Figure 53: North America Market Value Share (%) and BPS Analysis by Distribution Channel, 2022 to 2032
Figure 54: North America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022 to 2032
Figure 55: North America Market Attractiveness by Type, 2022 to 2032
Figure 56: North America Market Attractiveness by Range, 2022 to 2032
Figure 57: North America Market Attractiveness by Route of Administration , 2022 to 2032
Figure 58: North America Market Attractiveness by Indication, 2022 to 2032
Figure 59: North America Market Attractiveness by Distribution Channel, 2022 to 2032
Figure 60: North America Market Attractiveness by Country, 2022 to 2032
Figure 61: Latin America Market Value (US$ Mn) by Type, 2022 to 2032
Figure 62: Latin America Market Value (US$ Mn) by Range, 2022 to 2032
Figure 63: Latin America Market Value (US$ Mn) by Route of Administration , 2022 to 2032
Figure 64: Latin America Market Value (US$ Mn) by Indication, 2022 to 2032
Figure 65: Latin America Market Value (US$ Mn) by Distribution Channel, 2022 to 2032
Figure 66: Latin America Market Value (US$ Mn) by Country, 2022 to 2032
Figure 67: Latin America Market Value (US$ Mn) Analysis by Country, 2017 to 2032
Figure 68: Latin America Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 69: Latin America Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 70: Latin America Market Value (US$ Mn) Analysis by Type, 2017 to 2032
Figure 71: Latin America Market Value Share (%) and BPS Analysis by Type, 2022 to 2032
Figure 72: Latin America Market Y-o-Y Growth (%) Projections by Type, 2022 to 2032
Figure 73: Latin America Market Value (US$ Mn) Analysis by Range, 2017 to 2032
Figure 74: Latin America Market Value Share (%) and BPS Analysis by Range, 2022 to 2032
Figure 75: Latin America Market Y-o-Y Growth (%) Projections by Range, 2022 to 2032
Figure 76: Latin America Market Value (US$ Mn) Analysis by Route of Administration , 2017 to 2032
Figure 77: Latin America Market Value Share (%) and BPS Analysis by Route of Administration , 2022 to 2032
Figure 78: Latin America Market Y-o-Y Growth (%) Projections by Route of Administration , 2022 to 2032
Figure 79: Latin America Market Value (US$ Mn) Analysis by Indication, 2017 to 2032
Figure 80: Latin America Market Value Share (%) and BPS Analysis by Indication, 2022 to 2032
Figure 81: Latin America Market Y-o-Y Growth (%) Projections by Indication, 2022 to 2032
Figure 82: Latin America Market Value (US$ Mn) Analysis by Distribution Channel, 2017 to 2032
Figure 83: Latin America Market Value Share (%) and BPS Analysis by Distribution Channel, 2022 to 2032
Figure 84: Latin America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022 to 2032
Figure 85: Latin America Market Attractiveness by Type, 2022 to 2032
Figure 86: Latin America Market Attractiveness by Range, 2022 to 2032
Figure 87: Latin America Market Attractiveness by Route of Administration , 2022 to 2032
Figure 88: Latin America Market Attractiveness by Indication, 2022 to 2032
Figure 89: Latin America Market Attractiveness by Distribution Channel, 2022 to 2032
Figure 90: Latin America Market Attractiveness by Country, 2022 to 2032
Figure 91: Europe Market Value (US$ Mn) by Type, 2022 to 2032
Figure 92: Europe Market Value (US$ Mn) by Range, 2022 to 2032
Figure 93: Europe Market Value (US$ Mn) by Route of Administration , 2022 to 2032
Figure 94: Europe Market Value (US$ Mn) by Indication, 2022 to 2032
Figure 95: Europe Market Value (US$ Mn) by Distribution Channel, 2022 to 2032
Figure 96: Europe Market Value (US$ Mn) by Country, 2022 to 2032
Figure 97: Europe Market Value (US$ Mn) Analysis by Country, 2017 to 2032
Figure 98: Europe Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 99: Europe Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 100: Europe Market Value (US$ Mn) Analysis by Type, 2017 to 2032
Figure 101: Europe Market Value Share (%) and BPS Analysis by Type, 2022 to 2032
Figure 102: Europe Market Y-o-Y Growth (%) Projections by Type, 2022 to 2032
Figure 103: Europe Market Value (US$ Mn) Analysis by Range, 2017 to 2032
Figure 104: Europe Market Value Share (%) and BPS Analysis by Range, 2022 to 2032
Figure 105: Europe Market Y-o-Y Growth (%) Projections by Range, 2022 to 2032
Figure 106: Europe Market Value (US$ Mn) Analysis by Route of Administration , 2017 to 2032
Figure 107: Europe Market Value Share (%) and BPS Analysis by Route of Administration , 2022 to 2032
Figure 108: Europe Market Y-o-Y Growth (%) Projections by Route of Administration , 2022 to 2032
Figure 109: Europe Market Value (US$ Mn) Analysis by Indication, 2017 to 2032
Figure 110: Europe Market Value Share (%) and BPS Analysis by Indication, 2022 to 2032
Figure 111: Europe Market Y-o-Y Growth (%) Projections by Indication, 2022 to 2032
Figure 112: Europe Market Value (US$ Mn) Analysis by Distribution Channel, 2017 to 2032
Figure 113: Europe Market Value Share (%) and BPS Analysis by Distribution Channel, 2022 to 2032
Figure 114: Europe Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022 to 2032
Figure 115: Europe Market Attractiveness by Type, 2022 to 2032
Figure 116: Europe Market Attractiveness by Range, 2022 to 2032
Figure 117: Europe Market Attractiveness by Route of Administration , 2022 to 2032
Figure 118: Europe Market Attractiveness by Indication, 2022 to 2032
Figure 119: Europe Market Attractiveness by Distribution Channel, 2022 to 2032
Figure 120: Europe Market Attractiveness by Country, 2022 to 2032
Figure 121: South Asia Market Value (US$ Mn) by Type, 2022 to 2032
Figure 122: South Asia Market Value (US$ Mn) by Range, 2022 to 2032
Figure 123: South Asia Market Value (US$ Mn) by Route of Administration , 2022 to 2032
Figure 124: South Asia Market Value (US$ Mn) by Indication, 2022 to 2032
Figure 125: South Asia Market Value (US$ Mn) by Distribution Channel, 2022 to 2032
Figure 126: South Asia Market Value (US$ Mn) by Country, 2022 to 2032
Figure 127: South Asia Market Value (US$ Mn) Analysis by Country, 2017 to 2032
Figure 128: South Asia Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 129: South Asia Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 130: South Asia Market Value (US$ Mn) Analysis by Type, 2017 to 2032
Figure 131: South Asia Market Value Share (%) and BPS Analysis by Type, 2022 to 2032
Figure 132: South Asia Market Y-o-Y Growth (%) Projections by Type, 2022 to 2032
Figure 133: South Asia Market Value (US$ Mn) Analysis by Range, 2017 to 2032
Figure 134: South Asia Market Value Share (%) and BPS Analysis by Range, 2022 to 2032
Figure 135: South Asia Market Y-o-Y Growth (%) Projections by Range, 2022 to 2032
Figure 136: South Asia Market Value (US$ Mn) Analysis by Route of Administration , 2017 to 2032
Figure 137: South Asia Market Value Share (%) and BPS Analysis by Route of Administration , 2022 to 2032
Figure 138: South Asia Market Y-o-Y Growth (%) Projections by Route of Administration , 2022 to 2032
Figure 139: South Asia Market Value (US$ Mn) Analysis by Indication, 2017 to 2032
Figure 140: South Asia Market Value Share (%) and BPS Analysis by Indication, 2022 to 2032
Figure 141: South Asia Market Y-o-Y Growth (%) Projections by Indication, 2022 to 2032
Figure 142: South Asia Market Value (US$ Mn) Analysis by Distribution Channel, 2017 to 2032
Figure 143: South Asia Market Value Share (%) and BPS Analysis by Distribution Channel, 2022 to 2032
Figure 144: South Asia Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022 to 2032
Figure 145: South Asia Market Attractiveness by Type, 2022 to 2032
Figure 146: South Asia Market Attractiveness by Range, 2022 to 2032
Figure 147: South Asia Market Attractiveness by Route of Administration , 2022 to 2032
Figure 148: South Asia Market Attractiveness by Indication, 2022 to 2032
Figure 149: South Asia Market Attractiveness by Distribution Channel, 2022 to 2032
Figure 150: South Asia Market Attractiveness by Country, 2022 to 2032
Figure 151: East Asia Market Value (US$ Mn) by Type, 2022 to 2032
Figure 152: East Asia Market Value (US$ Mn) by Range, 2022 to 2032
Figure 153: East Asia Market Value (US$ Mn) by Route of Administration , 2022 to 2032
Figure 154: East Asia Market Value (US$ Mn) by Indication, 2022 to 2032
Figure 155: East Asia Market Value (US$ Mn) by Distribution Channel, 2022 to 2032
Figure 156: East Asia Market Value (US$ Mn) by Country, 2022 to 2032
Figure 157: East Asia Market Value (US$ Mn) Analysis by Country, 2017 to 2032
Figure 158: East Asia Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 159: East Asia Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 160: East Asia Market Value (US$ Mn) Analysis by Type, 2017 to 2032
Figure 161: East Asia Market Value Share (%) and BPS Analysis by Type, 2022 to 2032
Figure 162: East Asia Market Y-o-Y Growth (%) Projections by Type, 2022 to 2032
Figure 163: East Asia Market Value (US$ Mn) Analysis by Range, 2017 to 2032
Figure 164: East Asia Market Value Share (%) and BPS Analysis by Range, 2022 to 2032
Figure 165: East Asia Market Y-o-Y Growth (%) Projections by Range, 2022 to 2032
Figure 166: East Asia Market Value (US$ Mn) Analysis by Route of Administration , 2017 to 2032
Figure 167: East Asia Market Value Share (%) and BPS Analysis by Route of Administration , 2022 to 2032
Figure 168: East Asia Market Y-o-Y Growth (%) Projections by Route of Administration , 2022 to 2032
Figure 169: East Asia Market Value (US$ Mn) Analysis by Indication, 2017 to 2032
Figure 170: East Asia Market Value Share (%) and BPS Analysis by Indication, 2022 to 2032
Figure 171: East Asia Market Y-o-Y Growth (%) Projections by Indication, 2022 to 2032
Figure 172: East Asia Market Value (US$ Mn) Analysis by Distribution Channel, 2017 to 2032
Figure 173: East Asia Market Value Share (%) and BPS Analysis by Distribution Channel, 2022 to 2032
Figure 174: East Asia Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022 to 2032
Figure 175: East Asia Market Attractiveness by Type, 2022 to 2032
Figure 176: East Asia Market Attractiveness by Range, 2022 to 2032
Figure 177: East Asia Market Attractiveness by Route of Administration , 2022 to 2032
Figure 178: East Asia Market Attractiveness by Indication, 2022 to 2032
Figure 179: East Asia Market Attractiveness by Distribution Channel, 2022 to 2032
Figure 180: East Asia Market Attractiveness by Country, 2022 to 2032
Figure 181: Oceania Market Value (US$ Mn) by Type, 2022 to 2032
Figure 182: Oceania Market Value (US$ Mn) by Range, 2022 to 2032
Figure 183: Oceania Market Value (US$ Mn) by Route of Administration , 2022 to 2032
Figure 184: Oceania Market Value (US$ Mn) by Indication, 2022 to 2032
Figure 185: Oceania Market Value (US$ Mn) by Distribution Channel, 2022 to 2032
Figure 186: Oceania Market Value (US$ Mn) by Country, 2022 to 2032
Figure 187: Oceania Market Value (US$ Mn) Analysis by Country, 2017 to 2032
Figure 188: Oceania Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 189: Oceania Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 190: Oceania Market Value (US$ Mn) Analysis by Type, 2017 to 2032
Figure 191: Oceania Market Value Share (%) and BPS Analysis by Type, 2022 to 2032
Figure 192: Oceania Market Y-o-Y Growth (%) Projections by Type, 2022 to 2032
Figure 193: Oceania Market Value (US$ Mn) Analysis by Range, 2017 to 2032
Figure 194: Oceania Market Value Share (%) and BPS Analysis by Range, 2022 to 2032
Figure 195: Oceania Market Y-o-Y Growth (%) Projections by Range, 2022 to 2032
Figure 196: Oceania Market Value (US$ Mn) Analysis by Route of Administration , 2017 to 2032
Figure 197: Oceania Market Value Share (%) and BPS Analysis by Route of Administration , 2022 to 2032
Figure 198: Oceania Market Y-o-Y Growth (%) Projections by Route of Administration , 2022 to 2032
Figure 199: Oceania Market Value (US$ Mn) Analysis by Indication, 2017 to 2032
Figure 200: Oceania Market Value Share (%) and BPS Analysis by Indication, 2022 to 2032
Figure 201: Oceania Market Y-o-Y Growth (%) Projections by Indication, 2022 to 2032
Figure 202: Oceania Market Value (US$ Mn) Analysis by Distribution Channel, 2017 to 2032
Figure 203: Oceania Market Value Share (%) and BPS Analysis by Distribution Channel, 2022 to 2032
Figure 204: Oceania Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022 to 2032
Figure 205: Oceania Market Attractiveness by Type, 2022 to 2032
Figure 206: Oceania Market Attractiveness by Range, 2022 to 2032
Figure 207: Oceania Market Attractiveness by Route of Administration , 2022 to 2032
Figure 208: Oceania Market Attractiveness by Indication, 2022 to 2032
Figure 209: Oceania Market Attractiveness by Distribution Channel, 2022 to 2032
Figure 210: Oceania Market Attractiveness by Country, 2022 to 2032
Figure 211: MEA Market Value (US$ Mn) by Type, 2022 to 2032
Figure 212: MEA Market Value (US$ Mn) by Range, 2022 to 2032
Figure 213: MEA Market Value (US$ Mn) by Route of Administration , 2022 to 2032
Figure 214: MEA Market Value (US$ Mn) by Indication, 2022 to 2032
Figure 215: MEA Market Value (US$ Mn) by Distribution Channel, 2022 to 2032
Figure 216: MEA Market Value (US$ Mn) by Country, 2022 to 2032
Figure 217: MEA Market Value (US$ Mn) Analysis by Country, 2017 to 2032
Figure 218: MEA Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 219: MEA Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 220: MEA Market Value (US$ Mn) Analysis by Type, 2017 to 2032
Figure 221: MEA Market Value Share (%) and BPS Analysis by Type, 2022 to 2032
Figure 222: MEA Market Y-o-Y Growth (%) Projections by Type, 2022 to 2032
Figure 223: MEA Market Value (US$ Mn) Analysis by Range, 2017 to 2032
Figure 224: MEA Market Value Share (%) and BPS Analysis by Range, 2022 to 2032
Figure 225: MEA Market Y-o-Y Growth (%) Projections by Range, 2022 to 2032
Figure 226: MEA Market Value (US$ Mn) Analysis by Route of Administration , 2017 to 2032
Figure 227: MEA Market Value Share (%) and BPS Analysis by Route of Administration , 2022 to 2032
Figure 228: MEA Market Y-o-Y Growth (%) Projections by Route of Administration , 2022 to 2032
Figure 229: MEA Market Value (US$ Mn) Analysis by Indication, 2017 to 2032
Figure 230: MEA Market Value Share (%) and BPS Analysis by Indication, 2022 to 2032
Figure 231: MEA Market Y-o-Y Growth (%) Projections by Indication, 2022 to 2032
Figure 232: MEA Market Value (US$ Mn) Analysis by Distribution Channel, 2017 to 2032
Figure 233: MEA Market Value Share (%) and BPS Analysis by Distribution Channel, 2022 to 2032
Figure 234: MEA Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022 to 2032
Figure 235: MEA Market Attractiveness by Type, 2022 to 2032
Figure 236: MEA Market Attractiveness by Range, 2022 to 2032
Figure 237: MEA Market Attractiveness by Route of Administration , 2022 to 2032
Figure 238: MEA Market Attractiveness by Indication, 2022 to 2032
Figure 239: MEA Market Attractiveness by Distribution Channel, 2022 to 2032
Figure 240: MEA Market Attractiveness by Country, 2022 to 2032
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
Which segment is expected to dominate the global anti-infective agents market during 2022?
The anti-viral segment by product type is going to occupy a 61% global market share in 2022.
What will be the growth rate of the global anti-infective agents market during the forecast period?
The global anti-infective agents market is predicted to rise with a steady 3.3% CAGR during 2022 to 2032.
What is the present market value of the anti-infective agents market?
The global anti-infective agents market is currently worth more than US$ 136 Billion.
What will be the projected market size of the anti-infective agents market by 2032?
By 2032, the global anti-infective agents market is projected to reach a market size of US$ 195.8 Billion.
What is the outlook of the APAC anti-infective agents market during 2022 to 2032?
The APAC anti-infective agents market is expected to grow with a steady CAGR of 3.1% during 2022 to 2032.
What will be the outlook of the other segment during the forecast period?
The oral-route application segment will be the fastest growing segment during the forecast period with a 3.4% CAGR.
How is the North American anti-infective agents market projected to grow during 2022 to 2032?
The North American region is predicted to grow with a steady CAGR of 4% during 2022 to 2032.
At what rate did the anti-infective agents market flourish from 2017 to 2021?
During the historical period of 2017 to 2021, the anti-infective agents market grew at a CAGR of 2.2%.
Anti-Infective Agents Market